Cargando…

Genomic landscape of the individual host response and outcomes in sepsis: a prospective cohort study

BACKGROUND: Effective targeted therapy for sepsis requires an understanding of the heterogeneity in the individual host response to infection. We investigated this heterogeneity by defining interindividual variation in the transcriptome of patients with sepsis and related this to outcome and genetic...

Descripción completa

Detalles Bibliográficos
Autores principales: Davenport, Emma E, Burnham, Katie L, Radhakrishnan, Jayachandran, Humburg, Peter, Hutton, Paula, Mills, Tara C, Rautanen, Anna, Gordon, Anthony C, Garrard, Christopher, Hill, Adrian V S, Hinds, Charles J, Knight, Julian C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4820667/
https://www.ncbi.nlm.nih.gov/pubmed/26917434
http://dx.doi.org/10.1016/S2213-2600(16)00046-1
_version_ 1782425446785220608
author Davenport, Emma E
Burnham, Katie L
Radhakrishnan, Jayachandran
Humburg, Peter
Hutton, Paula
Mills, Tara C
Rautanen, Anna
Gordon, Anthony C
Garrard, Christopher
Hill, Adrian V S
Hinds, Charles J
Knight, Julian C
author_facet Davenport, Emma E
Burnham, Katie L
Radhakrishnan, Jayachandran
Humburg, Peter
Hutton, Paula
Mills, Tara C
Rautanen, Anna
Gordon, Anthony C
Garrard, Christopher
Hill, Adrian V S
Hinds, Charles J
Knight, Julian C
author_sort Davenport, Emma E
collection PubMed
description BACKGROUND: Effective targeted therapy for sepsis requires an understanding of the heterogeneity in the individual host response to infection. We investigated this heterogeneity by defining interindividual variation in the transcriptome of patients with sepsis and related this to outcome and genetic diversity. METHODS: We assayed peripheral blood leucocyte global gene expression for a prospective discovery cohort of 265 adult patients admitted to UK intensive care units with sepsis due to community-acquired pneumonia and evidence of organ dysfunction. We then validated our findings in a replication cohort consisting of a further 106 patients. We mapped genomic determinants of variation in gene transcription between patients as expression quantitative trait loci (eQTL). FINDINGS: We discovered that following admission to intensive care, transcriptomic analysis of peripheral blood leucocytes defines two distinct sepsis response signatures (SRS1 and SRS2). The presence of SRS1 (detected in 108 [41%] patients in discovery cohort) identifies individuals with an immunosuppressed phenotype that included features of endotoxin tolerance, T-cell exhaustion, and downregulation of human leucocyte antigen (HLA) class II. SRS1 was associated with higher 14 day mortality than was SRS2 (discovery cohort hazard ratio (HR) 2·4, 95% CI 1·3–4·5, p=0·005; validation cohort HR 2·8, 95% CI 1·5–5·1, p=0·0007). We found that a predictive set of seven genes enabled the classification of patients as SRS1 or SRS2. We identified cis-acting and trans-acting eQTL for key immune and metabolic response genes and sepsis response networks. Sepsis eQTL were enriched in endotoxin-induced epigenetic marks and modulated the individual host response to sepsis, including effects specific to SRS group. We identified regulatory genetic variants involving key mediators of gene networks implicated in the hypoxic response and the switch to glycolysis that occurs in sepsis, including HIF1α and mTOR, and mediators of endotoxin tolerance, T-cell activation, and viral defence. INTERPRETATION: Our integrated genomics approach advances understanding of heterogeneity in sepsis by defining subgroups of patients with different immune response states and prognoses, as well as revealing the role of underlying genetic variation. Our findings provide new insights into the pathogenesis of sepsis and create opportunities for a precision medicine approach to enable targeted therapeutic intervention to improve sepsis outcomes. FUNDING: European Commission, Medical Research Council (UK), and the Wellcome Trust.
format Online
Article
Text
id pubmed-4820667
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-48206672016-04-15 Genomic landscape of the individual host response and outcomes in sepsis: a prospective cohort study Davenport, Emma E Burnham, Katie L Radhakrishnan, Jayachandran Humburg, Peter Hutton, Paula Mills, Tara C Rautanen, Anna Gordon, Anthony C Garrard, Christopher Hill, Adrian V S Hinds, Charles J Knight, Julian C Lancet Respir Med Articles BACKGROUND: Effective targeted therapy for sepsis requires an understanding of the heterogeneity in the individual host response to infection. We investigated this heterogeneity by defining interindividual variation in the transcriptome of patients with sepsis and related this to outcome and genetic diversity. METHODS: We assayed peripheral blood leucocyte global gene expression for a prospective discovery cohort of 265 adult patients admitted to UK intensive care units with sepsis due to community-acquired pneumonia and evidence of organ dysfunction. We then validated our findings in a replication cohort consisting of a further 106 patients. We mapped genomic determinants of variation in gene transcription between patients as expression quantitative trait loci (eQTL). FINDINGS: We discovered that following admission to intensive care, transcriptomic analysis of peripheral blood leucocytes defines two distinct sepsis response signatures (SRS1 and SRS2). The presence of SRS1 (detected in 108 [41%] patients in discovery cohort) identifies individuals with an immunosuppressed phenotype that included features of endotoxin tolerance, T-cell exhaustion, and downregulation of human leucocyte antigen (HLA) class II. SRS1 was associated with higher 14 day mortality than was SRS2 (discovery cohort hazard ratio (HR) 2·4, 95% CI 1·3–4·5, p=0·005; validation cohort HR 2·8, 95% CI 1·5–5·1, p=0·0007). We found that a predictive set of seven genes enabled the classification of patients as SRS1 or SRS2. We identified cis-acting and trans-acting eQTL for key immune and metabolic response genes and sepsis response networks. Sepsis eQTL were enriched in endotoxin-induced epigenetic marks and modulated the individual host response to sepsis, including effects specific to SRS group. We identified regulatory genetic variants involving key mediators of gene networks implicated in the hypoxic response and the switch to glycolysis that occurs in sepsis, including HIF1α and mTOR, and mediators of endotoxin tolerance, T-cell activation, and viral defence. INTERPRETATION: Our integrated genomics approach advances understanding of heterogeneity in sepsis by defining subgroups of patients with different immune response states and prognoses, as well as revealing the role of underlying genetic variation. Our findings provide new insights into the pathogenesis of sepsis and create opportunities for a precision medicine approach to enable targeted therapeutic intervention to improve sepsis outcomes. FUNDING: European Commission, Medical Research Council (UK), and the Wellcome Trust. Elsevier 2016-04 /pmc/articles/PMC4820667/ /pubmed/26917434 http://dx.doi.org/10.1016/S2213-2600(16)00046-1 Text en © 2016 Davenport et al. Open Access article distributed under the terms of CC BY http://creativecommons.org/licenses/by/4.0/ This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Articles
Davenport, Emma E
Burnham, Katie L
Radhakrishnan, Jayachandran
Humburg, Peter
Hutton, Paula
Mills, Tara C
Rautanen, Anna
Gordon, Anthony C
Garrard, Christopher
Hill, Adrian V S
Hinds, Charles J
Knight, Julian C
Genomic landscape of the individual host response and outcomes in sepsis: a prospective cohort study
title Genomic landscape of the individual host response and outcomes in sepsis: a prospective cohort study
title_full Genomic landscape of the individual host response and outcomes in sepsis: a prospective cohort study
title_fullStr Genomic landscape of the individual host response and outcomes in sepsis: a prospective cohort study
title_full_unstemmed Genomic landscape of the individual host response and outcomes in sepsis: a prospective cohort study
title_short Genomic landscape of the individual host response and outcomes in sepsis: a prospective cohort study
title_sort genomic landscape of the individual host response and outcomes in sepsis: a prospective cohort study
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4820667/
https://www.ncbi.nlm.nih.gov/pubmed/26917434
http://dx.doi.org/10.1016/S2213-2600(16)00046-1
work_keys_str_mv AT davenportemmae genomiclandscapeoftheindividualhostresponseandoutcomesinsepsisaprospectivecohortstudy
AT burnhamkatiel genomiclandscapeoftheindividualhostresponseandoutcomesinsepsisaprospectivecohortstudy
AT radhakrishnanjayachandran genomiclandscapeoftheindividualhostresponseandoutcomesinsepsisaprospectivecohortstudy
AT humburgpeter genomiclandscapeoftheindividualhostresponseandoutcomesinsepsisaprospectivecohortstudy
AT huttonpaula genomiclandscapeoftheindividualhostresponseandoutcomesinsepsisaprospectivecohortstudy
AT millstarac genomiclandscapeoftheindividualhostresponseandoutcomesinsepsisaprospectivecohortstudy
AT rautanenanna genomiclandscapeoftheindividualhostresponseandoutcomesinsepsisaprospectivecohortstudy
AT gordonanthonyc genomiclandscapeoftheindividualhostresponseandoutcomesinsepsisaprospectivecohortstudy
AT garrardchristopher genomiclandscapeoftheindividualhostresponseandoutcomesinsepsisaprospectivecohortstudy
AT hilladrianvs genomiclandscapeoftheindividualhostresponseandoutcomesinsepsisaprospectivecohortstudy
AT hindscharlesj genomiclandscapeoftheindividualhostresponseandoutcomesinsepsisaprospectivecohortstudy
AT knightjulianc genomiclandscapeoftheindividualhostresponseandoutcomesinsepsisaprospectivecohortstudy